Evidence map›Paper›PMID 34430360›Full record

ArticleTranslational lung cancer research2021

Breast metastases from primary lung cancer: a retrospective case series on clinical, ultrasonographic, and immunohistochemical features.

Bo Wang, Ying Jiang, Shi Yu Li, Rui Lan Niu, Justin D Blasberg, Jussuf T Kaifi, Gang Liu, Zhi Li Wang

Open access · diamondAbstract read
In one paragraph

Article in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Lung cancer with breast metastasis: a case report and review of the literature.The Journal of international medical research · 2023
    Pooled it
  2. Article
  3. Clinical and imaging manifestations of metastases from rare sites.Quantitative imaging in medicine and surgery · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Bo WangDepartment of Ultrasound, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Ying JiangSchool of Medicine, Nankai University, Tianjin, China.
Shi Yu LiDepartment of Ultrasound, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Rui Lan NiuDepartment of Ultrasound, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Justin D BlasbergSection of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Jussuf T KaifiDivision for Cardiothoracic Surgery, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO, USA.
Gang LiuDepartment of Radiology, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Zhi Li WangDepartment of Ultrasound, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Chinese People's Liberation Army · CNNankai University · CNUniversity of Missouri · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundLung cancer metastases to the breast are less common and consequently have received much less attention in clinical practice. The purpose of this study was to provide a better understanding of clinical, ultrasonographic, and immunohistochemical features of breast metastases from primary lung cancer.

methodsThis retrospective case series included patients with breast metastases from primary lung cancer between January 2012 and December 2020. Clinical features, ultrasonographic characteristics, and immunohistochemical findings were evaluated in this analysis.

resultsIn all, 7 cases (mean ± standard deviation age: 57.4±8.3 years; range, 49-70 years) were evaluated. The maximum size of breast lesions in 6 cases ranged from 1.2 to 4.5 cm, while 1 case showed a diffused pattern. Ultrasound features of breast metastases from lung cancer were irregular (5/7, 71.4%), indistinct (6/7, 85.7%), hypoechoic (7/7, 100.0%), and parallel (6/7, 85.7%) masses without calcification. Immunohistochemical staining test was positive for thyroid transcription factor 1 (TTF-1) in all patients (7/7, 100.0%), 3 cases (3/5, 60.0%) were negative for p63, 5 cases (5/5, 100.0%) were positive for cytokeratin 7 (CK7), 4 cases (4/5, 80.0%) were positive for napsin A.

conclusionsThe ultrasonographic features of lung metastases to the breast are clinically important to understand. A known history of the primary lung cancer is of great importance when evaluating patients with a breast nodule. The presence of an ipsilateral lung cancer, breast nodule and axillary lymphadenopathy should be considered with pathological and immunohistochemical data to differentiate breast metastases from a primary breast malignancy in this setting.

Indexed as

Breast metastasescase seriesimmunohistochemistrylung cancerultrasonography

Identifiers

PMID34430360
PMCPMC8350075
OpenAlexW3184590003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.